share_log

Appili Therapeutics Inc. (TSE:APL) to Post FY2023 Earnings of ($0.09) Per Share, Zacks Small Cap Forecasts

Defense World ·  Sep 5, 2022 01:51

Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap boosted their FY2023 earnings estimates for shares of Appili Therapeutics in a note issued to investors on Thursday, September 1st. Zacks Small Cap analyst D. Bautz now anticipates that the company will post earnings per share of ($0.09) for the year, up from their previous estimate of ($0.10).

Get Appili Therapeutics alerts:

Appili Therapeutics (TSE:APL – Get Rating) last issued its quarterly earnings data on Friday, August 12th. The company reported C($0.03) earnings per share (EPS) for the quarter, hitting the consensus estimate of C($0.03). The business had revenue of C$0.01 million for the quarter.

Appili Therapeutics Stock Performance

Further Reading

  • Could Snap Stock Rebound As Management Restructures?
  • MarketBeat: Week in Review 8/29 – 9/2
  • Hormel Looks Cheap At These Levels
  • Lululemon Set To Soar Into September
  • Could Nike Stock be Oversold, but Still Overvalued?

Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment